Ronald Herbst PhD

Ronald Herbst, PhD, serves as Vice President of Research and Development and Head of Oncology Research for MedImmune. Dr Herbst is responsible for the overall oncology research strategy and pre-clinical development of novel drug candidates. He joined MedImmune in February, 2006 as associate director of oncology research. He was Senior Principal Investigator in the Oncology Department at Schering-Plough Biopharma (formerly DNAX). He has been Member of Scientific Advisory Board at Definiens AG since September 15, 2015.